Compliance with medicine.
Compliance with medication regimens is critical in assessing the effectiveness of treatments. As new drugs are approved for marketing and prescribed to diverse patient populations, the FDA now recommends further observational studies to continuously monitor unforeseen side effects or efficacy. More research is needed to develop valid and reliable tools to assess adherence of patients to treatment recommendations and adherence of patients to treatment guidelines, when applicable. Information on adherence is a relevant to physicians and their patients as it is to insurers and payers, who need to implement cost-effective disease management programs. This review also has highlighted examples in the adherence literature specific to glaucoma medications and based on longitudinal survival analyses of claims data. Such results may be best complemented by primary, survey-based data collected from patients in observational studies.
Shaya
Fadia T
FT
Department of Pharmaceutical Health Services Research, Center on Drugs and Public Policy, University of Maryland School of Pharmacy, 515 West Lombard Street, Room #256, Baltimore, MD 21201, USA. fshaya@rx.umaryland.edu
D002986:Clinical Trials as Topic / Q000379:methods* / Q000523:psychology; D005128:Eye Diseases / Q000188:drug therapy; D019983:Guideline Adherence; D006801:Humans; D009885:Ophthalmology; D010349:Patient Compliance